NCT01889251View on ClinicalTrials.gov

A Phase III Study of A01016 in Subjects With Symptomatic Vitreomacular Adhesion

PHASE3CompletedINTERVENTIONAL
Enrollment

251

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Symptomatic Vitreomacular Adhesion
Interventions
DRUG

Ocriplasmin

DRUG

Sham injection

Trial Locations (1)

Unknown

Contact Alcon for Trial Locations, Tokyo

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT01889251 - A Phase III Study of A01016 in Subjects With Symptomatic Vitreomacular Adhesion | Biotech Hunter | Biotech Hunter